Brief: Tracon Pharmaceuticals Inc - Tribunal In Arbitration Against I-Mab Rendered An Award To Tracon Of About $23.0 Million
25/04/2023 13:49
TRACON Pharmaceuticals Inc TCON.O :
* TRACON PHARMACEUTICALS INC - TRIBUNAL IN ARBITRATION
AGAINST
I-MAB RENDERED AN AWARD TO TRACON OF ABOUT $23.0 MILLION
* TRACON PHARMACEUTICALS INC - BELIEVE WILL EXTEND RUNWAY
INTO
2024 PAST EXPECTED INTERIM EFFICACY RESULTS FROM ENVASARC
Source text for Eikon: ID:nGNXMJ3kz
Further company coverage: TCON.O
Recent news on TRACON Pharmaceuticals
See all newsBrief: TRACON Pharmaceuticals Says ENVASARC Trial ORR Is 5%, Does Not Meet 11% Endpoint
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Files For Offering Of Common Stock, Pre-Funded Warrants